Novo Nordisk (NVO) has pledged DKK 42B ($6B) from 2023 through the next six years to expand production capacity in its home country. The investment will go into ramping up production at existing ...
Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...
New York, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Voximplant, a leading cloud communications and Voice AI platform, announced native support for xAI's Grok Voice Agent API for real-time, ...
ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
SAN FRANCISCO--(BUSINESS WIRE)--Postman, the world’s leading API collaboration platform, today released the findings of its sixth annual 2024 State of the API Report, the industry’s most comprehensive ...
Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...
With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...
Bruker is hosting a webinar that will examine the PIPAc project in more detail. This exciting initiative is reshaping pharmaceutical manufacturing by combining AI, in-line NMR, flow chemistry, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback